News | September 07, 2023
Biocon Biologics completes integration of Viatris Biosimilars’ business in North America
Biocon Biologics recently acquired the global biosimilars business of its long-term partner Viatris
Biocon Biologics recently acquired the global biosimilars business of its long-term partner Viatris
This collaboration marks a significant milestone in countering the disease burden by enhancing access to products for patients in the US
The companies will spread the adoption of the latest HOS and Mass Spec technologies to help scientists improve the safety, stability, and effectiveness of biotherapeutics
Patients Treated with ARIKAYCE plus macrolide-based background regimen had meaningfully larger improvements in QOL-B respiratory score
This is a strategic acquisition for Cipla South Africa to unlock the future growth opportunities in the South African market
The cognitively operated system is a mother patent invention, first launched in India
Amgen will be prohibited from leveraging its drug portfolio to disadvantage rivals and will be required to seek prior approval before acquiring related products
The facility has a potential for capacity expansion up to 2 billion tablets/capsules per year
Health Assurance is a unique healthcare model that combines health insurance with preventive healthcare with a focus on keeping people healthy while providing sick care for them when needed
Robots make it to the healthcare conference panel, reflecting the future potential of technology
Subscribe To Our Newsletter & Stay Updated
